donderdag 22 maart 2012 - Nederlandse Vereniging voor Gastro ...

Donderdag 22 maart 2012
COIN study group and Dutch Initiative on Crohn and Colitis, 1 Dept. of Gastroenterology and
Hepatology, University Medical Center Utrecht, Utrecht, 2 Julius Center for Health Sciences
and Primary Care, University Medical Center Utrecht, Utrecht, 3 Dept. of Gastroenterology
and Hepatology, University Medical Center Groningen, Groningen, 4 Dept. of Gastroenterology
and Hepatology, VU University Medical Center, Amsterdam, 5 Dept. of
Gastroenterology and Hepatology, Radboud University Nijmegen Medical Center, Nijmegen,
6Dept. of Gastroenterology and Hepatology, Maastricht University Medical Center,
Maastricht, The Netherlands, 7 Dept. of Gastroenterology and Hepatology, Erasmus
University Medical Center, Rotterdam, 8 Dept. of Gastroenterology and Hepatology, Orbis
Medical Center, Sittard, 9 Dept. of Gastroenterology and Hepatology, Diaconessenhuis,
Leiden, 10 Dept. of Gastroenterology and Hepatology, Onze Lieve Vrouwe Gasthuis,
Amsterdam, 11 Dept. of Gastroenterology and Hepatology, Slingeland Hospital, Doetinchem,
12Dept. of Gastroenterology and Hepatology, Antonius Hospital, Nieuwegein, 13 Dept. of
Gastroenterology and Hepatology, Academic Medical Center Amsterdam, 14 Dept. of
Gastroenterology and Hepatology, Reinier de Graaf Groep, Delft, 15 Dept. of Gastroenterology
and Hepatology, Meander Medical Center, Amersfoort, The Netherlands
11.00 Parent of origin effects for IL12B and NOD2 in Inflammatory Bowel Disease
K. Fransen 1,2 , M. Mitrovic 1,3 , C.C. van Diemen 1 , B.K. Thelma 4 , S. Senapati 4 , U. Potocnik 3 , H.
W. Verspagert 5 , C.IJ. Ponsioen 6 , D. de Jong 7 , I. Nolte 8 , R. K. Weersma 1 , 1 Dept. of Gastroenterology
and Hepatology, University Medical Centre Groningen, University of Groningen,
Groningen, The Netherlands, 2 Dept. of Genetics, University Medical Centre Groningen and
University of Groningen, Groningen, The Netherlands, 3 Center for Human Molecular
Genetics and Pharmacogenomics, Medical Faculty, University of Maribor, Maribor, Slovenia,
4Dept. of Genetics, University of Delhi, South Campus, New Delhi, India, 5 Dept. of
Gastroenterology and Hepatology, University Medical Centre Leiden, University of Leiden,
Leiden, The Netherlands, 6 Dept. of Gastroenterology and Hepatology, Academic Medical
Centre, Amsterdam, The Netherlands, 7 Dept. of Gastroenterology and Hepatology, Radboud
University Nijmegen Medical Centre, Nijmegen, The Netherlands, 8 Dept. of epidemiology,
University Medical Centre Groningen and University of Groningen, Groningen, The
Netherlands
11.10 Screening for opportunistic infections prior to TNF-alpha inhibitor treatment in
Crohn’s disease and the risk of severe infections
T.D.G. Belderbos 1 , M. van der Have 1 , H.H. Fidder 1 , M. Leenders 1 , G. Dijkstra 2 , C.P. Peters 3 ,
E.J. Eshuis 3 , C.Y. Ponsioen 3 , P.D. Siersema 1 , M.G.H. van Oijen 1 , B. Oldenburg 1 on behalf of
the Dutch Initiative on Crohn’s and Colitis (ICC), 1 Dept. of Gastroenterology and Hepatology,
University Medical Center Utrecht, Utrecht, 2 Dept. of Gastroenterology and Hepatology,
University Medical Center Groningen, Groningen, 3 Dept. of Gastroenterology and Hepatology,
Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
11.20 Extensive screening for opportunistic infections prior to biological therapy in patients
with Crohn’s disease is not cost-effective
M. van der Have, B. Oldenburg, H.H. Fidder, T. Belderbos, F. van der Scheer, P.D. Siersema,
M.G. van Oijen, Dept. of Gastroenterology and Hepatology, University Medical Center
Utrecht, The Netherlands
11.30 Ledenvergadering Nederlandse Vereniging voor Gastroenterologie Brabantzaal
12.00 Lunchbuffet in de expositiehal
12